1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Romania Pharmaceuticals and Healthcare Report Q2 2016

Romania Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 77 pages

Includes 3 FREE quarterly updates

BMI View: In line with Romania's economic outperformance in Europe, the country's pharmaceutical andhealthcare markets will see strong growth given increased consumer spending power and higher healthcarecontributions. However, aggressive drug pricing regulations, including the imminent joint drugprocurement agreement with Bulgaria will limit revenue earning opportunities.

Headline Expenditure Projections

- Pharmaceuticals: RON14.94bn (USD3.73bn) in 2015 to RON16.16bn (USD3.91bn) in 2016; 8.2% inlocal currency terms and 4.9% in US dollar terms.

- Healthcare: RON33.84bn (USD8.45bn) in 2015 to RON34.95bn (USD8.46bn) in 2016; 3.3% in localcurrency terms and 0.2% in US dollar terms.

Table Of Contents

Romania Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Romania 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Romania 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Romania 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Romania 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Romania 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Romania 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Romania 2012-2020) 20
Generic Medicine Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Romania 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Romania 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Romania 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Romania 2014-2020) 28
Pharmaceuticals and Healthcare Risk/Reward Index 29
Central And Eastern Europe Risk/Reward Index 29
Romania Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Intellectual Property Issues 37
Corruption 38
Pricing Regime 39
Reimbursement Regime 40
Market Overview 44
Healthcare System 45
Table: Healthcare Resources (Romania 2010-2015) 48
Table: Healthcare Personnel (Romania 2010-2015) 48
Table: Healthcare Activity (Romania 2010-2015) 49
Research And Development 49
Clinical Trials 50
Epidemiology 51
Competitive Landscape 54
Research-Based Industry 54
Table: Members Of ARPIM, 2016 54
Table: Multinational Market Activity 55
Generic Drugmakers 56
Pharmaceutical Distribution 57
Pharmaceutical Retail Sector 57
Company Profile 59
Antibiotice Iasi 59
LaborMed Pharma 62
Terapia Ranbaxy 64
Demographic Forecast 66
Table: Population Headline Indicators (Romania 1990-2025) 67
Table: Key Population Ratios (Romania 1990-2025) 67
Table: Urban/Rural Population and Life Expectancy (Romania 1990-2025) 68
Table: Population By Age Group (Romania 1990-2025) 68
Table: Population By Age Group % (Romania 1990-2025) 69
Glossary 71
Methodology 73
Pharmaceutical Expenditure Forecast Model 73
Healthcare Expenditure Forecast Model 73
Notes On Methodology 74
Risk/Reward Index Methodology 75
Index Overview 76
Table: Pharmaceutical Risk/Reward Index Indicators 76
Indicator Weightings 77

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.